Article
Upregulated-flotillins and sphingosine kinase 2 derail vesicular trafic to stabilize AXL…
medRxiv · 2021 · Genest, M.; Comunale, F.; Planchon, D.; Govindin, P.; Vacher, S.; Bieche, I.; Robert, B.; Malhotra, H.; Schoenit, A.; Tashireva, L.; Gauthier-Rouviere, C.; Bodin, S.
Key facts
| Title | Upregulated-flotillins and sphingosine kinase 2 derail vesicular trafic to stabilize AXL and promote epithelial-mesenchymal transition |
|---|---|
| First author | Genest, M.; Comunale, F.; Planchon, D.; Govindin, P.; Vacher, S.; Bieche, I.; Robert, B.; Malhotra, H.; Schoenit, A.; Tashireva, L.; Gauthier-Rouviere, C.; Bodin, S. |
| Journal | medRxiv |
| Published | May 28, 2021 |
| DOI | 10.1101/2020.05.12.090571 |
| Devices mentioned | 090571 |
| Product codes mentioned | DDG, DQK, DSI, MXZ, NDS, PCA, JCI, JJH, JJQ, KIT, KPA, MVU and 6 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1